浙江医学
浙江醫學
절강의학
ZHEJIANG MEDICAL JOURNAL
2015年
12期
1022-1026
,共5页
滕卫军%郑晓娟%华宏军%林峰
滕衛軍%鄭曉娟%華宏軍%林峰
등위군%정효연%화굉군%림봉
胃癌%长链非编码RNA%细胞增殖
胃癌%長鏈非編碼RNA%細胞增殖
위암%장련비편마RNA%세포증식
Gastric cancer%Long non- coding RNA%Cell proliferation
目的:分析胃癌组织特征长链非编码RNA(lncRNA)表达谱,并探讨长链非编码RNA UCA1在胃癌中的表达及效应。方法采用基因芯片检测6例胃癌患者的肿瘤组织及癌旁正常组织LncRNA表达水平,分析胃癌组织特征lncRNA表达谱,进一步通过定量PCR检测40例胃癌及其对应的癌旁正常组织中UCA1的表达并分析淋巴结转移、肿块大小、细胞分化程度及病理分期等临床病理特征的关系。在此基础上,利用siRNA下调AGS胃癌细胞内UCA1表达水平,利用CCK-8试剂盒检测UCA1干预对胃癌细胞增殖能力的影响。结果 LncRNA基因芯片检测到胃癌组织1021条差异>2倍的lncRNA(P<0.05),定量PCR验证明显差异表达的UCA1在胃癌组织中的表达显著高于正常组织(P<0.01)。此外,临床病理相关分析显示,UCA1表达水平还与胃癌的细胞分化程度及病理分期相关。分化低的胃癌组织中UCA1表达水平明显高于中、高分化的胃癌组织(P<0.05);病理分期Ⅲ/Ⅳ期胃癌组织的UCA1表达水平明显高于Ⅰ/Ⅱ期的标本(P<0.05)。此外,下调UCA1胃癌细胞表达可明显抑制细胞增殖。结论异常表达的lncRNA参与了胃癌的发生、发展,其中肿瘤组织上调表达的UCA1是胃癌重要的促癌基因。
目的:分析胃癌組織特徵長鏈非編碼RNA(lncRNA)錶達譜,併探討長鏈非編碼RNA UCA1在胃癌中的錶達及效應。方法採用基因芯片檢測6例胃癌患者的腫瘤組織及癌徬正常組織LncRNA錶達水平,分析胃癌組織特徵lncRNA錶達譜,進一步通過定量PCR檢測40例胃癌及其對應的癌徬正常組織中UCA1的錶達併分析淋巴結轉移、腫塊大小、細胞分化程度及病理分期等臨床病理特徵的關繫。在此基礎上,利用siRNA下調AGS胃癌細胞內UCA1錶達水平,利用CCK-8試劑盒檢測UCA1榦預對胃癌細胞增殖能力的影響。結果 LncRNA基因芯片檢測到胃癌組織1021條差異>2倍的lncRNA(P<0.05),定量PCR驗證明顯差異錶達的UCA1在胃癌組織中的錶達顯著高于正常組織(P<0.01)。此外,臨床病理相關分析顯示,UCA1錶達水平還與胃癌的細胞分化程度及病理分期相關。分化低的胃癌組織中UCA1錶達水平明顯高于中、高分化的胃癌組織(P<0.05);病理分期Ⅲ/Ⅳ期胃癌組織的UCA1錶達水平明顯高于Ⅰ/Ⅱ期的標本(P<0.05)。此外,下調UCA1胃癌細胞錶達可明顯抑製細胞增殖。結論異常錶達的lncRNA參與瞭胃癌的髮生、髮展,其中腫瘤組織上調錶達的UCA1是胃癌重要的促癌基因。
목적:분석위암조직특정장련비편마RNA(lncRNA)표체보,병탐토장련비편마RNA UCA1재위암중적표체급효응。방법채용기인심편검측6례위암환자적종류조직급암방정상조직LncRNA표체수평,분석위암조직특정lncRNA표체보,진일보통과정량PCR검측40례위암급기대응적암방정상조직중UCA1적표체병분석림파결전이、종괴대소、세포분화정도급병리분기등림상병리특정적관계。재차기출상,이용siRNA하조AGS위암세포내UCA1표체수평,이용CCK-8시제합검측UCA1간예대위암세포증식능력적영향。결과 LncRNA기인심편검측도위암조직1021조차이>2배적lncRNA(P<0.05),정량PCR험증명현차이표체적UCA1재위암조직중적표체현저고우정상조직(P<0.01)。차외,림상병리상관분석현시,UCA1표체수평환여위암적세포분화정도급병리분기상관。분화저적위암조직중UCA1표체수평명현고우중、고분화적위암조직(P<0.05);병리분기Ⅲ/Ⅳ기위암조직적UCA1표체수평명현고우Ⅰ/Ⅱ기적표본(P<0.05)。차외,하조UCA1위암세포표체가명현억제세포증식。결론이상표체적lncRNA삼여료위암적발생、발전,기중종류조직상조표체적UCA1시위암중요적촉암기인。
Objective To investigate the profiles of long non- coding RNA (lncRNA) expression in gastric cancer tis-sue. Methods The expression of lncRNAs was detected with microarray assay in 6 samples of gastric tumor and matched ad-jacent tissues. The profiles of lncRNAs in gastric cancer tissues were identified. The UCA1 expression was evaluated by re-al- time reverse transcription polymerase chain reaction (RT- PCR) in 40 gastric tumor samples and matched adjacent tissues. The correlations of UCA1 expression with lymph node metastasis, tumor size, cel differentiation, pathological stage were further analyzed. Tumor cel proliferation was assessed fol owing siRNA knockdown of UCA1 by using the CCK 8 kits. Results A total of 1 021 lncRNA expressed in gastric tumor samples>2 folds than matched adjacent tissues were identified (P<0.05) using mi-croarray assay. RT- PCR showed that the expression of UCA1 was significantly highly in gastric cancer than that in adjacent tis-sues (P<0.0001). High UCA1 expression was associated with cel differentiation and pathological stage of gastric cancer. UCA1 expression in low- differentiated gastric cancer was significantly higher than that in with high- differentiated cancer (P=0.031). In addition, UCA1 level in stageⅢ/Ⅳgastric cancer was significantly higher than that with stage I/II cancer (P=0.013). Furthermore, inhibition of UCA expression suppressed the proliferation of gastric cancer cel s. Conclusion Abnormal expression of LncRNA may be involved in the development of gastric cancer. Up- expression of UCA1 in tumor tissue might act as an oncogene and promote the development of gastric cancer.